Key facts
- Notable investors include Decheng Fund.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Yuda Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Yuda Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yuda Biotechnology
Manufacturer of of biotechnology products intended for pharmaceutical enterprises, healthcare providers, and industrial biotechnology sectors. The company focuses on the research, development, and commercialization of innovative biological products and technologies, thereby enabling clients to improve product efficacy, accelerate scientific progress, and support sustainable development.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
Yuda Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yuda Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yuda Biotechnology in its N-PORT filings yet. We sweep new filings monthly.